pH titration studies of an SH2 domain-phosphopeptide complex: Unusual histidine and phosphate pK(a) values

Protein Science

Volumn 6, Issue 9, 1997, Pages 1910-1919

  Singer, Alex U ^b   Forman Kay, Julie D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

Histidine; NMR; Phospholipase C ; Phosphotyrosine; pK(a) determination; SH2 domain

Indexed keywords

PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CELL PH; ENZYME ACTIVITY; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENTIAL ANALYSIS; TITRIMETRY;

EID: 0030767535     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560060912     Document Type: Article

References (54)

1. 15N NMR resonances and determination of the structure of the alkylated histidine. J Am Chem Soc 115: 1088-1094.
2. 1H chemical-shift calculation of proteins. J Magn Reson 98:646-653.
3. 15N NMR spectroscopy of hydrogen-bonding interactions in the active site of serine proteases: Evidence for a moving histidine mechanism. Biochemistry 25:7751-7759.
4. 15N-labeled histidine in aqueous solution. J Am Chem Soc 99:8149-8159.
5. Boyko R, Sykes B. 1993. CRVFIT - Version 3.0. Edmonton, Alberta.
6. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeiler J, Bax A. 1995. NMR Pipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277-293.
7. as of ionizable residues in proteins: An explicit solvent calculation for lysozyme. Proteins Struct Funct Genet 20:85-97.
8. Eck MJ, Shoelson SE, Harrison SC. 1993. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p561ck. Nature 362:81-91.
9. 15N NMR relaxation. Biochemistry 33:5984-6003.
10. 15N longitudinal decay and chemical exchange rates of systems in slow equilibrium. J Biomol NMR 4:727-734.
11. Garrett DS, Powers R, Gronenborn AM, Clore GM. 1991. A common sense approach to peak picking in two-, three-and four-dimensional spectra using automatic computer analysis of contour diagrams. J Magn Reson 95:214-220.
12. Gilmer T, Rodriguez M, Jordan S, Crosby R, Alligood K, Green M, Kimery M, Wagner C, Kinder D, Charifson P, Hassell AM, Willard D, Luther M, Rusnak D, Sternbach DD, Mehrotra M, Peel M, Shampine L, Davis R, Robbins J, Patel IR, Kassel D, Burkhart W, Mover M, Bradshaw T, Berman J. 1994. Peptide inhibitors of Src SH3-SH2 phosphoprotein interactions. J Biol Chem 269:31711-31719.
13. Gilson MK. 1995. Theory of electrostatic interactions in macromolecules. Curr Opin Struct Biol 5:216-223.
14. 15N-enriched calcineurin B. J Biomol NMR 3:627-638.
15. 13C NMR. Biochemistry 35:1-6.
16. Kay LE, Muhandiram DR, Farrow NA, Aubin Y, Forman-Kay JD. 1996. Correlation between dynamics and high affinity binding in an SH2 domain interaction. Biochemistry 35:361-368.
17. Kraulis PJ. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946-950.
18. Larose L, Gish G, Shoelson S, Pawson T. 1993. Identification of residues in the β platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-γ1. Oncogene 8:2493-2499.
19. Lee C-H, Kominos D, Jacques S, Margolis B, Schlessinger J, Shoelson SE, Kuriyan J. 1994. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure 2:423-438.
20. lck. Biochemistry 33:5070-5076.
21. Lodi PJ, Knowles JR. 1991. Neutral imidazole is the electrophile in the reaction catalyzed by triosphosphate isomerase: Structural origins and catalytic implications. Biochemistry 30:6948-6956.
22. Lodi PJ, Knowles JR. 1993. Direct evidence for the exploitation of an α-helix in the catalytic mechanism of triosephosphate isomerase. Biochemistry 32:4338-4343.
23. Mahadevan D, Thanki N, McPhie P, Beeler JF, Yu J-C, Wlodawer A, Heidaran MA. 1994. Comparison of calcium-dependent conformational changes in the N-terminal SH2 domains of p85 and GAP defines distinct properties for SH2 domains. Biochemistry 33:746-754.
24. Maignan S, Guilloteau J-P, Fromage N, Arnoux B, Becquart J, Ducruix A. 1995. Crystal structure of the mammalian Grb2 adaptor. Science 268:291-293.
25. Marangere LEM, Pawson T. 1992. Identification of residues in GTPase-activating protein Src Homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62. J Biol Chem 267:22779-22786.
26. Molecular Simulations Inc. 1993. QUANTA, version 4.0. Waltham, Massachusetts.
27. Narula S, Yuan R, Adams S, Green O, Green J, Philips T, Zydowsky L, Botfield M, Hatada M, Laird E, Zoller M, Karas M, Dalgarno D. 1995. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Structure 3:1061-1073.
28. Nishimura R, Li W, Kashishian A, Mondino A, Zhou M, Cooper J, Schlessinger J. 1993. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol Cell Biol 75:6889-6896.
29. Nolte R, Eck MJ, Schlessinger J, Shoelson SE, Harrison SC. 1996. Crystal structure of the PI3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat Struct Biol 3:364-374.
30. Nozaki Y, Tanford C. 1967. Examination of titration behavior. Methods Enzvmol 11:715-734.
31. Olivier JP, Raabe T, Henkemeyer M, Dickson B, Mbamalu G, Margolis B, Schlessinger J, Hafen E, Pawson T. 1993. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of ras guanine nucleotide exchange, Sos. Cell 75:179-191.
32. Panayotou G, Gish G, End P, Truong O, Gout I, Dhand R, Fry MJ, Hiles I, Pawson T, Waterfield MD. 1993. Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor β-receptor sequences: Analysis of kinetic parameters by a novel biosensor-based approach. Mol Cell Biol 13:3567-3576.
33. Pascal SM, Singer AU, Gish G, Yamazaki T, Shoelson SE, Pawson T, Kay LE, Forman-Kay JD. 1994. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a high affinity binding peptide. Cell 77:461-472.
34. Pascal SM, Singer AU, Gish G, Yamazaki T, Shoelson SE, Pawson T, Kay LE, Forman-Kay JD. 1997. High precision structure of a phospholipase C-γ1 SH2 domain-phosphopeptide complex reveals intermolecular hydrogen bonds and bound water. Forthcoming.
35. Pascal SM, Yamazaki T, Singer AU, Kay LE, Forman-Kay J. 1995. Structural and dynamical characterization of the phosphotyrosine binding region of a Src Homology 2 domain-phosphopeptide complex by NMR relaxation, proton exchange, and chemical shift approaches. Biochemistry 54:11353-11362.
36. Glc, a signal-transducing protein from Escherichia coli, using two-dimensional heteronuclear NMR techniques. Protein Sci 2:543-558.
37. 1 in solution: Correlation with NMR and x-ray data and insights into biological function. J Mol Biol 254:771-792.
38. Qin J, Clore GM, Gronenbom A. 1996. Ionization equilibria for side-chain carboxyl groups in oxidized and reduced human thioredoxin and in the complex with its target peptide from the transcription factor NFκB. Biochemistry 35:7-13.
39. Schaffhausen B. 1995. SH2 domain structure and function. Biochim Biophys Acta 1242:61-75.
40. Songyang Z, Shoelson SE, McGlade J, Olivier JP, Pawson T, Bustelo RX, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA, Cantley LC. 1994. Specific motifs recognized by the SH2 domains of csk, 3BP2, fes/fps, Grb-2, SHPTP1, SHC, Syk and vav. Mol Cell Biol 14:2777-2785.
41. Songyang ZS, Shoelson S, Chaudhuri M, Gish G, Pawson T, Hase W, King F, Roberts T, Ratnofsky S, Lechleider R, Neel B, R. Birge JF, Chou M, Hanafusa H, Shaffhausen B, Cantley L. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
42. 1H HSQC spectra of proteins. J Magn Reson A 107:178-184.
43. 1H-NMR Study on the tautomerism of the imidazole ring of histitine residues. 1. Microscopic pK values and molar ratios of tautomers in histidine-containing peptides. Biochim Biophys Acta 742:576-585.
44. 1H NMR spectroscopy of the catalytic histidine in choromethyl ketone-inhibited complexes of serine proteases. Biochemistry 55:2437-2444.
45. 15N NMR spectroscopy. Biochemistry 29:8164-8171.
46. mt1, a domain of the phosphoenolpyruvate-dependent mannitol-specific transport protein. Biochemistry 31:9063-9072.
47. Vogel HJ. 1989. Phosphorus-31 NMR of phosphoproteins. Methods Enzymol 177:263-282.
48. Waksman G, Shoelson SE, Pant N, Cowhum D, Kuriyan J. 1993. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 Domain: Crystal structures of the complexed and peptide-free forms. Cell 72:779-790.
49. Wuthrich K. 1986. NMR of proteins and nucleic acids. New York: Wiley.
50. c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry 34:2107-2121.
51. 13C-labeled proteins via scalar couplings. J Am Chem Soc 115:11054-11055.
52. 1H chemical shift in proteins. J Am Chem Soc 117:3556-3564.
53. Yonezawa K, Ueda H, Hara K, Nishida K, Ando A, Chavanieu A, Matsuba H, Shii K, Yokono K, Fukui Y, Calas B, Grigorescu F, Dhand R, Gout I, Otsu M, Waterfield MD, Kasuga M. 1992. Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1. J Biol Chem 267:25958-25966.
54. 15N resonance assignments of the N-terminal SH3 domain of drk in the folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques. J Biomol NMR 4:845-858.